altRx vs IVIM Health: Price, Protocols, and Ratings Compared
Comparing altRx vs IVIM Health quickly: altRx positions itself as the most affordable GLP-1 program with semaglutide starting at $89/month, while IVIM Health highlights strong third-party ratings and a structured GLP-1 ID protocol with a free month code. Early verdict: choose altRx for lowest advertised starting price and simple pricing; choose IVIM Health for verified high ratings and a proprietary clinician-guided protocol.
Start altRx: semaglutide from $89/mo
Key differences at a glance: price, protocol, and trust signals
This comparison focuses on the most supported differences between altRx and IVIM Health: starting price and price structure, program protocol and clinical claims, third party review signals, medication and regulatory notes, and membership or fees. Both providers prescribe compounded GLP-1 medications and operate via telehealth, but they present different value propositions.
1. Price and how fees are presented
altRx leads on headline affordability: semaglutide starting at $89/month and tirzepatide at $149/month. altRx markets this as a limited offer and emphasizes same price every month, no membership, and pay later options. IVIM Health lists semaglutide at $75/month in some captured materials but publishes a pricing path that includes a program fee and ongoing rates: a free-month promo with code GIFT75, tirzepatide at $133/month plus a $74.99/mo program fee, and ongoing pricing noted in IVIM materials as $174/month after promotional rates. altRx highlights all-inclusive monthly pricing that covers medical oversight, medication, and support. IVIM’s price presentation includes an initial free month option and a program fee that increases the effective monthly cost for many patients.
Try IVIM Health: free month with code GIFT75
2. Program structure and clinical protocol
altRx provides 100% online medical visits, a 2-minute quiz to start, and says a licensed provider will review evaluations and deliver a personalized plan. If appropriate, altRx may prescribe compounded semaglutide or compounded tirzepatide and ships medication from state-licensed 503A compounding pharmacies. IVIM Health emphasizes a proprietary GLP-1 ID protocol described as clinician-guided titration and optimization, and IVIM claims this protocol can accelerate weight loss up to 40% compared to a referenced GLP-1 trial, with the important qualifier that this is IVIM’s protocol claim and not a head-to-head independent trial.
3. Trust signals and evidence
altRx markets affordability and convenience but does not present third-party rating claims in the supplied evidence. IVIM Health highlights unusually strong external verification with 4.9-star ratings on both Google and Trustpilot and cites peer-reviewed retrospective observational studies published in Obesity Pillars that it uses to support clinical outcomes, noting these are not randomized head-to-head trials.
4. Medication status and regulatory notes
Both providers use compounded GLP-1 medications. The sources clearly state that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. altRx notes prescriptions are filled by state-licensed compounding pharmacies in its network. IVIM also indicates medications are prepared by independent licensed compounding pharmacies and that compounded products carry risks and may not be appropriate for everyone.
Side by side comparison table
| Criteria | altRx | IVIM Health |
|---|---|---|
| Starting price | Semaglutide from $89/mo; Tirzepatide $149/mo | Semaglutide listed $75/mo in capture; ongoing pricing examples include $174/mo after promos |
| Promotions and fees | Limited offer pricing; no membership or hidden fees; buy now pay later available | Free month with code GIFT75; $74.99/mo program fee noted; initial free consult included |
| Program model | 100% online medical visits; personalized care plan; 2-day discreet delivery | Clinician-guided GLP-1 ID protocol with structured titration and optimization |
| Third-party ratings | No dual 4.9-star claim supplied | 4.9 stars on Google and Trustpilot per IVIM materials |
| Medication type | Compounded semaglutide and tirzepatide via 503A pharmacies | Compounded semaglutide and tirzepatide from licensed compounding pharmacies |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
What each provider emphasizes most
altRx emphasizes affordability, transparent all-inclusive monthly pricing, no membership, and 100% online care. IVIM Health emphasizes verified satisfaction metrics, a clinician-guided GLP-1 ID protocol, and promotional offers that reduce upfront cost such as a free month and a free consultation.
Get altRx pricing and start the 2-minute quiz
Available evidence limits
This comparison uses only supplied source material. It does not provide independent clinical efficacy conclusions or availability beyond the providers claims. Specific state availability and prescribing authority vary by state as stated by each provider. Neither source provides a head-to-head clinical trial comparing the two services directly.
Sign up with altRx for $89/mo semaglutide
Conclusion and final recommendation
altRx vs IVIM Health comes down to priorities. altRx is the clear choice if lowest advertised starting price and simple, all-inclusive monthly billing are your top priorities. IVIM Health is the clearer choice if independent third-party ratings and a structured clinician-guided protocol matter more, and if you plan to use promotional offers like the free month code.
Choose altRx if you want the lowest advertised starting price and an all-inclusive, cancel anytime monthly plan. Choose IVIM Health if you prefer a program with dual 4.9-star ratings and IVIM’s proprietary GLP-1 ID protocol.